Considering the social issues and necessity of cell gene therapy, we would like to inform you that the two drugs were listed after negotiations, completed through consultations with related organizations such as the Ministry of Health and Welfare for the rapid listing of the super expensive new drugs Kymria and Zolgensma.

For more datails, please visit website of the Ministry of Health and Welfare and Health Insurance Review & Assessment Service. 

Thank you.